Prudential Financial
TVRD

Prudential Financial’s Tvardi Therapeutics TVRD Stock Holding History

Prudential Financial’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,215
Closed -$215K – 2726
2023
Q1 		$215K Sell
1,215
-55
-4% -$18.4K ﹤0.01% 2382
2022
Q4 		$491K Hold
1,270
– – ﹤0.01% 2033
2022
Q3 		$428K Buy
1,270
+57
+5% +$20.6K ﹤0.01% 2138
2022
Q2 		$399K Sell
1,213
-10
-0.8% -$3.51K ﹤0.01% 2222
2022
Q1 		$535K Sell
1,223
-17
-1% -$6.98K ﹤0.01% 2175
2021
Q4 		$544K Buy
1,240
+10
+0.8% +$5.03K ﹤0.01% 2173
2021
Q3 		$684K Sell
1,230
-66
-5% -$33.1K ﹤0.01% 2008
2021
Q2 		$666K Buy
+1,296
New +$821K ﹤0.01% 2026

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's TVRD Position: Q2 2023 in Review

Prudential Financial sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 1,215 shares — an estimated $215K sold.

Prudential Financial first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $684K in Q3 2021. 136 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

  • Prudential Financial reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Prudential Financial sold 1,215 Tvardi Therapeutics shares in Q2 2023, an estimated $215K.
  • Prudential Financial first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
  • Prudential Financial's Tvardi Therapeutics position peaked at $684K in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.